trending Market Intelligence /marketintelligence/en/news-insights/trending/um2lCe-wmZdbKkKhg4FuAg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In this list

Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Innovus Pharmaceuticals undertaking 1-for-105 reverse stock split

Innovus Pharmaceuticals Inc. is implementing a 1-for-105 reverse split of its common stock.

The San Diego-based pharmaceutical company said its stock will begin trading on a split-adjusted basis on the OTCQB marketplace at the opening of trading March 18.

The reverse stock split was approved by a majority of Innovus' stockholders Feb. 22.